
In this episode of Models & Molecules, René Hoet reflects on game-changing technologies like phenotypic screening, the unique innovation dynamics of small biotechs versus large pharma, and the real-world impact of AI in antibody discovery. We touch upon bridging academia and industry and discuss why taking calculated risks is essential for the next breakthroughs in drug discovery.Read the full conversation here.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

Melody Shahsavarian | Agentic AI and the Digital Transformation of Pharma R&D

Iddo Weiner | Data, moats, and open science: Building scalable AI applications for bio

Talip Uçar | Inside Boltz's open-source bet on the future of AI-driven drug discovery

Steve Comeau | From novel binder design to the realities of AI in complex therapeutics
Free AI-powered recaps of Models & Molecules and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.